![](/img/cover-not-exists.png)
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect
Shawn G Clouthier, Kenneth R Cooke, Takanori Teshima, Kathleen P Lowler, Chen Liu, Kevin Connolly, James L.M FerraraVolume:
9
Year:
2003
Language:
english
DOI:
10.1016/s1083-8791(03)00230-1
File:
PDF, 300 KB
english, 2003